| scholarly article | Q13442814 |
| P50 | author | Janet Treasure | Q15968782 |
| Meredith Yeager | Q28025162 | ||
| David Goldman | Q30505567 | ||
| Andrew W Bergen | Q42754234 | ||
| Kelly Klump | Q56283505 | ||
| Marianne Bernadette van den Bree | Q58807370 | ||
| Dorothy E Grice | Q72542627 | ||
| P2093 | author name string | Kaplan A | |
| Bulik CM | |||
| Kaye WH | |||
| Haque K | |||
| Strober M | |||
| Welch R | |||
| Berrettini WH | |||
| Ganjei JK | |||
| Bacanu S | |||
| Fichter M | |||
| Woodside B | |||
| Halmi K | |||
| P2860 | cites work | Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior | Q24315738 |
| Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta | Q24338360 | ||
| Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 | ||
| Regional expression and chromosomal localization of the delta opiate receptor gene | Q24564675 | ||
| Variant detection at the delta opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence | Q28138352 | ||
| Characterization of single-nucleotide polymorphisms in coding regions of human genes | Q28138557 | ||
| A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains | Q28145391 | ||
| Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor | Q28235534 | ||
| Chromosomal localization of the delta opioid receptor gene to human 1p34.3-p36.1 and mouse 4D bands by in situ hybridization | Q28244218 | ||
| Identification of a human delta opioid receptor: cloning and expression | Q28254698 | ||
| Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus | Q28771769 | ||
| The future of genetic studies of complex human diseases | Q29547215 | ||
| Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior | Q33702882 | ||
| Anorexia nervosa and major depression: shared genetic and environmental risk factors | Q33891941 | ||
| Opioid site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes. | Q33898796 | ||
| A preliminary population-based twin study of self-reported eating disorder | Q33936447 | ||
| Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample | Q33946602 | ||
| Candidate gene polymorphisms in eating disorders | Q34116518 | ||
| Persistent perfectionism, symmetry, and exactness after long-term recovery from anorexia nervosa | Q34289191 | ||
| A note on power approximations for the transmission/disequilibrium test | Q34389414 | ||
| Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. | Q37361553 | ||
| Temperament and character in women with anorexia nervosa | Q38463785 | ||
| Brain serotonin and eating behavior | Q39459771 | ||
| Serotonin and appetite | Q40096674 | ||
| The spectrum of behaviors influenced by serotonin | Q40847700 | ||
| Genomewide transmission/disequilibrium testing--consideration of the genotypic relative risks at disease loci | Q40875822 | ||
| Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes | Q41722632 | ||
| Stimulation of food intake by muscimol and beta endorphin | Q43473232 | ||
| A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity | Q44272429 | ||
| Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders | Q44342377 | ||
| Association between a delta opioid receptor gene polymorphism and heroin dependence in man. | Q44346554 | ||
| Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence | Q44352797 | ||
| Personality features of women with good outcome from restricting anorexia nervosa. | Q46034344 | ||
| Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge. | Q47336112 | ||
| Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? | Q47429668 | ||
| The anorexic effect of naltrexone is independent of its suppressant effect on water intake | Q49117555 | ||
| Linkage analysis of anorexia nervosa incorporating behavioral covariates. | Q51958717 | ||
| Model-free analysis and permutation tests for allelic associations. | Q52027186 | ||
| The family based association test method: strategies for studying general genotype--phenotype associations. | Q52065297 | ||
| A search for susceptibility loci for anorexia nervosa: methods and sample description. | Q53336449 | ||
| Naloxone in the treatment of anorexia nervosa: effect on weight gain and lipolysis | Q70693407 | ||
| High-throughput single nucleotide polymorphism genotyping by fluorescent 5' exonuclease assay | Q72998295 | ||
| Eating disorders: progress and problems | Q74594324 | ||
| Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa | Q77139431 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anorexia nervosa | Q131749 |
| opioid | Q427523 | ||
| serotonin | Q167934 | ||
| P304 | page(s) | 397-406 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa | |
| P478 | volume | 8 |
| Q39294002 | 5-HT3 receptors: A potential therapeutic target for epilepsy |
| Q34329590 | A debate on current eating disorder diagnoses in light of neurobiological findings: is it time for a spectrum model? |
| Q29417089 | A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa |
| Q36106407 | A review and primer of molecular genetic studies of anorexia nervosa. |
| Q37308305 | Academy for eating disorders position paper: eating disorders are serious mental illnesses |
| Q40141898 | An empirical study of the typology of bulimic symptoms in young Portuguese women |
| Q34413819 | Anorexia nervosa: definition, epidemiology, and cycle of risk |
| Q38013059 | Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials |
| Q46513883 | Association of multiple DRD2 polymorphisms with anorexia nervosa |
| Q42678499 | Association study in eating disorders: TPH2 associates with anorexia nervosa and self-induced vomiting. |
| Q34235895 | Association study of 182 candidate genes in anorexia nervosa |
| Q35857670 | Contemporary thinking about the role of genes and environment in eating disorders. |
| Q36916902 | Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes |
| Q33731374 | Eating disorders: the current status of molecular genetic research |
| Q43025657 | Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa |
| Q33939778 | Exploring the gene-environment nexus in eating disorders. |
| Q61713904 | Functional Pharmacogenetics of Serotonin Receptors in Psychiatric Drug Action |
| Q34370439 | Genetic neuropathology of obsessive psychiatric syndromes. |
| Q35941387 | Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives |
| Q64250176 | Genetic risk factors for eating disorders: an update and insights into pathophysiology |
| Q37293990 | Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions |
| Q28943295 | Genetic variants associated with disordered eating |
| Q35897259 | Genetics and Epigenetics of Eating Disorders |
| Q89060260 | Genetics and Epigenetics of Eating Disorders |
| Q33788144 | Genome-wide association analysis and functional annotation of positional candidate genes for feed conversion efficiency and growth rate in pigs |
| Q36219483 | Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36 |
| Q58112108 | Hypnotic Alteration of Body Image in the Eating Disordered |
| Q84401512 | Identification of novel candidate loci for anorexia nervosa at 1q41 and 11q22 in Japanese by a genome-wide association analysis with microsatellite markers |
| Q38753914 | Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa. |
| Q37139316 | Interspecies genetics of eating disorder traits |
| Q34766044 | Lifetime course of eating disorders: design and validity testing of a new strategy to define the eating disorders phenotype |
| Q35899657 | Machine learning derived risk prediction of anorexia nervosa |
| Q47656495 | Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness. |
| Q26738448 | New Insights in Anorexia Nervosa |
| Q39051440 | OPRD1 Genetic Variation and Human Disease. |
| Q35982317 | Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice |
| Q48207870 | Rapid remission of anorexia nervosa and unconscious communication |
| Q35586604 | Refinement of behavioural traits in animals for the genetic dissection of eating disorders |
| Q91337965 | Rigor and reproducibility in genetic research on eating disorders |
| Q37788537 | Role of the evolutionarily conserved starvation response in anorexia nervosa |
| Q37938794 | Serotonin and molecular neuroimaging in humans using PET. |
| Q64449738 | The Genetics of Anorexia Nervosa |
| Q28761964 | The Genetics of Anorexia Nervosa: Current Findings and Future Perspectives |
| Q37127485 | The genetics of anorexia nervosa collaborative study: methods and sample description |
| Q33746241 | The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation |
| Q33747706 | Validity and utility of subtyping anorexia nervosa |
| Q81141547 | [Anorexic and bulimic eating disorders] |
Search more.